Charing Cross International Symposium 2025 has released 12 podium first sessions to be presented at its 47th annual vascular symposium.

CX 2025 is set to take place from the 23rd to 25th April at ExCeL London. Access the full programme here.

Day 1: Peripheral Arterial Challenges

Wednesday 23rd April, 08:06am – 16:28pm (BST)

• First report of the 12-month data from the SUCCESS PTA study: Sirolimus DCB in real-world patients with peripheral arterial disease – Presented by Dr Michael Lichtenberg
• One-year outcomes of the SIRONA RCT: Paclitaxel coated vs. Limus coated DCB in femoro-popliteal disease: Deep dive into clinical endpoints – Presented by Prof Ulf Teichgräber
• Real-world data of sirolimus-coated balloon versus POBA for CLTI patients: 3-year outcomes of TLR, AFS and survival from HOPE registry – Presented by Dr Edward Choke
• Drug-eluting stent vs. bare device therapies for PAD In the real world: 12-month amputation and readmission rates in a large population – Presented by Dr Brian DeRubertis
• REALDES study: Three-year results of a real-world study of two drug-eluting stents for femoro-popliteal treatments – Presented by Dr Peter Schneider
• An update and new cost-effectiveness data from the LIFE-BTK RCT – Presented by Dr Sahil Parikh
• An update on the first-in-human and ELITE-BTK trials – Presented by Dr Eric Secemsky
• An update on 3-year results of the MOTIV trial – Presented by Dr Michel Bosiers
• First data release on a DRS for the femoro-popliteal segment – Presented by Dr Andrew Holden
• Comparing one paclitaxel-eluting stent to other stents in PAD: A systematic meta-analysis – Presented by Dr Andrew Holden
• Two-year results of the SPORTS trial: DCB vs. DES vs. BMS in femoro-popliteal disease – Presented by Dr Gunnar Tepe
• An update from BASIL-3: Health economic and pooled mortality analyses – Presented by Mr Matthew Popplewell
• Which vessel preparation techniques are best in the SFA: A multidisciplinary global consensus group using a modified Delphi process – Presented by Prof Fabrizio Fanelli
• Plain balloon angioplasty vs. intra-vascular lithotripsy vs. atherectomy as vessel preparation tools prior to the application of drug-coated balloons – Presented by Dr Hany Zayed
• New IVL technologies and trial data for calcified tibial artery disease – Presented by Dr Andrew Holden
• Update on a new laser intravascular lithotripsy technology – Presented by Dr Marianne Brodmann
• Current literature supports endovascular-first strategy in TASC-D aorto-iliac lesions – Presented by Prof Maarit Venermo
• Covered stents vs. uncovered stents in AIOD: An update on the FORWARD randomised trial – Presented by Dr Andrew Holden
• Covered endovascular reconstruction of aortic bifurcation (CERAB): Long-term outcomes of the CERAB-UK multi-centre UK registry – Presented by Dr Arsalan Wafi
• Long-term 5-year outcomes after percutaneous DVA: Experience from a pioneer programme in Singapore showing persistent perfusion – Presented by Dr Steven Kum
• One-year clinical and lifetime cost-effectiveness outcomes of transcatheter arterialisation for no-option CLTI in the UK – Presented by Dr Hany Zayed
• Results of the PESTO trial – Presented by Prof Thomas Zeller

Day 1: Aortic Techniques and Technologies

Wednesday 23rd April,13:30pm – 13:40pm (BST)

• Results of unsupported fenestrated sealing system in complex AAA – Presented by Prof Antoine Millon

Day 1: Vascular Access Masterclass

Wednesday 23rd April, 09:20am – 15:25pm (BST)

• Real-world endoAVF outcomes: STAR registry data from 1000 patients - Wednesday, 23rd April – Presented by Dr Rashid Sharaf
• ACCESS 2: A randomised controlled multinational AVF trial evaluating outcomes following intra-operative periadventitial delivery of Sirolimus – Presented by Dr Nicholas Inston
• IN.PACT AV access post approval study demographic data – Presented by Dr Sanjay Misra
• 12-month outcomes from the WAVE study – Presented by Dr Robert Jones
• Optimal treatment of cephalic arch stenosis based on recent Level 1 DCB and covered stent trial results – Presented by Dr Bart Dolmatch
• The FLEX FIRST AV registry – Presented by Dr Ari Kramer

Day 2 Morning: Juxtarenal & Aorto-Iliac Challenges

Thursday 24th April, 09:30am – 12:05pm (BST)

• Variations in juxtarenal AAA repair: A Swedvasc and Vascunet analysis – Presented by Prof Kevin Mani
• Standardised 4 fenestrated PMEG: Insights from the SPhERE multi-centre registry using a new algorithm – Presented by Dr Michele Piazza
• Evaluating the proposal of the ESVS AAA guidelines to stratify surveillance after EVAR in a single-centre – Presented by Prof Hence Verhagen

Day 2 Afternoon: Abdominal Aortic Aneurysm Challenges

Thursday 24th April, 13:30pm – 17:05pm (BST)

• Improving treatment for men with RAAA – Presented by Prof Jacob Budtz-Lilly
• Recognising and treating abdominal compartment syndrome is more important than ever in the era of EVAR for rAAA – Presented by Prof Martin Bjorck
• Can proteomics analyses predict sac shrinkage after EVAR? – Presented by Dr Alexander Zimmermann
• The impact of blood pressure on AAA growth rates: A prospective longitudinal cohort study – Presented by Mr Colin Bicknell
• First-in-human study on a local stabilising agent for small to medium-sized AAA – Presented by Dr Andrew Holden
• Challenging anatomy cohort data supporting 90-degree neck angulation with up to 10mm infrarenal seal – Presented by Dr Robert Rhee
• Risk stratification and treatment selection in patients with asymptomatic AAAs – Presented by Dr Lorenz Meuli

Day 2: Venous & Lymphatic Challenges

Thursday 24th April, 09:20am – 15:15pm (BST)

• Interim analysis of STRIKE-PE: CAVT for acute PE – Presented by Prof Andrew Sharp
• Results of perivenous dexamethasone injection after thrombus removal for acute femoropopliteal – Presented by Prof David Dexter
• Prospective clinical trial evaluating cyanoacrylate closure in patients with C6 disease – Presented by Mr Manj Gohel

Day 2 Morning: Carotid & Acute Stroke Challenges

Thursday 24th April, 12:30pm – 12:35pm (BST)

• PERFORMANCE II: First European presentation of the two year outcomes – Presented by Prof William Gray

Day 2 Afternoon: Peripheral Arterial Techniques & Technologies

Thursday 24th April, 13:42pm – 17:48pm (BST)

• First 12-month real-world data of a drug-eluting balloon angioplasty in complex femeropopliteal lesions – Presented by Dr Efthymios Beropoulis
• Systematic review and meta-analysis of over 300 original research articles on the use of atherectomy for peripheral endovascular interventions – Presented by Prof Thomas Zeller
• One-year results of using self-expanding stent grafts in the iliacs: First outcomes outcomes from the PMCF study – Presented by Prof Michel Reijnen
• CERAB technique in the management of complex aortoiliac disease in patients with critical limb ischaemia: Preliminary data from the global CERAB registry – Presented by Dr Maria Antonella Ruffino
• A novel double layer braided nitinol stent for femoro-popliteal lesion: Preliminary results from a multi-centre registry – Presented by Prof Gianmarco de Donato

Day 3 Morning: Aortic Arch & Dissection Challenges

Friday 25th April, 08:50am – 08:55am (BST)

• Interim results of a randomised controlled study on CO2 flushing in TEVAR and TAVI - Friday, 25th April – Presented by Dr Lydia Hanna

Day 3 Morning: Chronic Limb-Threatening Ischaemia Challenges

Friday 25th April, 09:15am – 11:30pm (BST)

• Ultra-distal bypasses under local anaesthetic – Presented by Mr Hani Slim
• Addressing poor physiological function and frailty in CLTI to improve outcomes – Presented by Prof Stacie Hodge
• MIDFUT RCT trial results: Efficacy of hydrosurgical debridment, NPWT and cadaveric dermis grafts in DFU healing – Presented by Dr David Russell
• Addressing poor physiological function and frailty in CLTI to improve outcomes – Presented by Dr Adam Haque
• BASIL-2: BEST CLI/GLASS angiographic scoring – Presented by Mr Matthew Popplewell
• BASIL-2 prospective cohort study: Outcomes of those managed conservatively – Presented by Mr Matthew Popplewell
• Cost-effectiveness data from BEST-CLI – Presented by Dr Matthew Menard
• Sub-set analysis from BEST-CLI provides more evidence on who benefits from a surgical or endovascular first approach – Presented by Dr Alik Farber
• Development of a core outcome set for studies assessing interventions for diabetes-related foot ulceration – Presented by Prof Robert Hinchliffe

Day 3 Afternoon: Thoracic Aortic Challenges

Friday 25th April, 14:00pm – 17:55pm (BST)

• International expert consensus on the management of acute aortic syndrome with PAU/IMH – Presented by Dr Michele Piazza
• Dangers of pushing the envelope too far in reducing the profile of thoracic stent grafts – Presented by Dr Frank Arko
• First insights to the European aortic data collection (EADC) – Presented by Dr Tilo Koelbel
• Real-world outcomes for thoracoabdominal inner branch off the shelf device – Presented by Dr Alexander Oberhuber
• Latest TAMBE results of the highest volume centre in the pivotal trial – Presented by Dr Steven Maximus
• Results of a multi-centre Unitary Stent Graft study – Presented by Dr Patrick Kelly

Day 3 Morning: Vascular Trauma Challenges

Friday 25th April, 09:00am – 09:10am (BST)

• Endovascular first strategy for trauma – Presented by Dr Vikram Puttaswamy

References

CX Symposium. CX 2025 Programme. 2025. https://www.cxsymposium.com/cx-events-2025/ (accessed 28 March 2025).